Microfluidics Market Growth, Trends, Analysis and Forecasts To 2024 Microfluidics Market

Global Microfluidics Market: Accuracy and Quick
Analysis to Fuel Growth, says TMR
The competition in the global microfluidics market is exceptionally high due to the strong presence of
several global players in the overall market. The leading players held a share of 53% in the global market
in 2016. Danaher Corporation, Thermo Fisher Scientific, and F. Hoffman-La Roche AG hold a dominant
position in the overall market due to their extensive product portfolio and a growing geographical presence,
states Transparency Market Research
According to the research report, the global microfluidics market is expected to reach a valuation of
US$12.45 bn by the end of 2025 as compared to US$ 4.76 bn in 2016. During the forecast years of 2016
and 2025, the overall market is expected to expand at a CAGR of 11.4%.
To Get Sample Of the Reports @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18716
North America to Lead Global Market due to Adoption of Innovative Products
On the basis of product, the global market is segmented into microfluidic chips, instruments, cartridges and
reagents, and others. Of these, cartridges and reagents are expected to lead the market due to their
extensive usage in assays and techniques. Advantages of using these such as improved accuracy, quick
analysis, and reduced reagent consumption is expected to drive their demand in the coming years. The
report estimates the cartridges and reagents segment will progress at a CAGR of 12.2% between 2017 and
2025.
On the basis of geography, the global microfluidics market is segmented into Latin America, Asia Pacific,
Europe, North America, and the Middle East and Africa. North America is anticipated to dominate the global
market during the forecast period and is poised to acquire a share of 35.4% during the forecast period. The
adoption of innovative products in areas such as point of care testing and in vitro diagnostics is expected
to keep the regional market at the forefront.
Reduced Costs to Ensure Swift Uptake of Microfluidics Technology
“Microfluidic technologies come with a wide range of advantages that have become their strong selling
points,” states the lead author of this research report. The industrial market has shown a keen interest in
the microfluidics systems and technologies as they have considerable reduced the costs of procedures,
ensured faster time-to-results, lesser wastage of reagents, and smaller size and weight of devices or
products. The market is also expected to benefit from the growing demand for point-of-care diagnostics due
their cost-effectiveness. Furthermore, ability of ensure quick diagnosis of various diseases and disorders is
expected to augment the demand for microfluidics tools in the coming years. The ever-increasing pool of
geriatrics that is prone to various chronic disease such as diabetes, cancer, cardiovascular conditions, and
infectious diseases are also estimated provide the global market an adequate fillip.
Slow Rate of Approval to Hamper Market Growth